Reliance Pharma Fund (Bonus) NAV | Reliance Mutual Fund | Reliance Pharma Fund (Bonus) Investment

MARKET RADAR

SENSEX NIFTY Refresh

You are here : Moneycontrol > Mutual Funds > Sector - Pharma & Healthcare > Reliance Mutual Fund > Reliance Pharma Fund (Bonus)

SNAPSHOT

SNAPSHOT

Performance

Investment Info

Peers

Portfolio

News and Videos

News Videos

ranking by CRISIL

Not Ranked

This scheme is not ranked by CRISIL.
View Top ranked funds in other categories

Benchmark Index:

View Historic Graph From To

Returns (NAV as on May-22-2013)

Period	Returns (%)	Rank #
1 mth	4.8	2
3 mth	8.2	3
6 mth	9.0	3
1 year	27.1	2
2 year	14.2	2
3 year	13.2	3
5 year	24.3	1

# Moneycontrol Rank within 3 Sector - Pharma & Healthcare Schemes.

Absolute Returns (in %)

Year	Qtr 1	Qtr 2	Qtr 3	Qtr 4	Annual
2013	-6.3	-	-	-	-
2012	8.6	4.0	10.7	5.7	34.9
2011	-8.0	7.5	-7.5	-4.2	-11.6
2010	11.0	8.7	0.9	6.6	32.0
2009	-5.4	33.0	40.9	-0.2	116.7
2008	-29.1	0.6	3.4	-10.6	-35.0

View where it stands within its peers

* Returns over 1 year are Annualised

Returns Calculator SIP Calculator

EXPAND ALL

Performance

Fund returns v/s Category average (Sector - Pharma & Healthcare)

* Returns over 1 year are Annualised

	1 mth (%)	3 mth (%)	6 mth (%)	1 yr (%)	2 yr (%)	3 yr (%)	5yr (%)
Fund Returns	4.8	8.2	9.0	27.1	14.2	13.2	24.3
Category avg	4.7	9.1	12.0	29.4	16.6	15.4	18.6
Difference of Fund returns and Category returns	0.1	-0.9	-3.0	-2.3	-2.4	-2.2	5.7
Best of category	5.4	10.4	13.7	34.0	21.7	18.8	24.3
Worst of category	4.0	8.2	9.0	27.1	13.8	13.2	14.5
Benchmark returns #	5.9	11.7	15.9	35.7	21.9	19.3	16.2
Difference of Fund returns and Benchmark returns	-1.1	-3.5	-6.9	-8.6	-7.7	-6.1	8.1

# Benchmark Index: S&P BSE HEALTHCARE

Investment Info

Investment Objective

The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.

Scheme details

Fund Type	Open-Ended
Investment Plan	Bonus
Launch date	May 26, 2004
Benchmark	S&P BSE HEALTHCARE
Asset Size (Rs cr)	652.29 (Mar-30-2013)
Minimum Investment	Rs.5000
Last Dividend	N.A. View Dividend History
Bonus	N.A.
Fund Manager	Sailesh Raj Bhan View performance of schemes managed by the Fund Manager
Notes	N.A

Load Details

Entry Load	N.A
Exit Load	1.00%
Load Comments	Exit load - 1% if redeemed/switched out on or before completion of 1 yrs from the date of allotment.

Contact Details

Regd. Office	Kamala Mills Compound, Trade World, B-Wing, Senapati Bapat Marg, Lower Parel (W), Mumbai, 400013
Tel. No.	022-30994600
Fax No.	91 22 30414899
Email	response@reliancemutual.com
Website	http://www.reliancemutual.com/

Peer Comparison

Sector - Pharma & Healthcare	Crisil Rank	Assets (Rs.cr)
Sector - Pharma & Healthcare	Crisil Rank	Assets (Rs.cr)	3mth (%)	6mth (%)	1yr (%)	3yr (%)	5yr (%)
Reliance Pharma Fund (G)	Not Ranked	652.29	8.2	9.0	27.1	13.2	24.3
SBI Pharma Fund (G)	Not Ranked	66.50	8.6	13.2	34.0	18.8	14.5
UTI Pharma & Health (G)	Not Ranked	103.47	10.4	13.7	27.1	14.3	16.9
* Returns over 1 year are Annualised	More »

Portfolio

Top Holdings (Apr 30, 13)

Equity	Sector	Value (Rs cr)	Asset %
Divis Labs	Pharmaceuticals	75.24	10.99
Ranbaxy Labs	Pharmaceuticals	63.27	9.24
Sanofi India	Pharmaceuticals	62.82	9.17
Cipla	Pharmaceuticals	61.75	9.02
Dr Reddys Labs	Pharmaceuticals	57.82	8.44
Sun Pharma Adv	Pharmaceuticals	48.46	7.08
Sun Pharma	Pharmaceuticals	47.55	6.94
GlaxoSmithKline	Pharmaceuticals	42.51	6.21
Indoco Remedies	Pharmaceuticals	36.34	5.31
Abbott India	Pharmaceuticals	30.88	4.51